In our study, tumour cells of pCCA demonstrated high GAL immunoreactivity, with similar mean expression in comparison to healthy cholangiocytes pCCA patients with available survival rates (n = 18) were divided into two groups; high GAL expressors and low GAL expressors. The gene discussed is GAL; the disease is neoplasm.